SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial

BACKGROUND: Urothelial bladder cancer (UBC) accounts for 10,000 new diagnoses and 5000 deaths annually in the UK (Cancer Research UK, http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bladder-cancer, Cancer Research UK, Accessed 26 Mar 2018). Cisplatin-b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Crabb, Simon, Danson, Sarah J., Catto, James W. F., McDowell, Cathy, Lowder, James N., Caddy, Joshua, Dunkley, Denise, Rajaram, Jessica, Ellis, Deborah, Hill, Stephanie, Hathorn, David, Whitehead, Amy, Kalevras, Mihalis, Huddart, Robert, Griffiths, Gareth
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5883402/
https://ncbi.nlm.nih.gov/pubmed/29615077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-2586-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky